Document is current
Any future updates will be listed below
-
Authors
Vanderniet, Joel A. https://orcid.org/0000-0002-7063-6667
Tsinas, Dionysios
Wall, Christie-Lee
Girgis, Christian M.
London, Kevin
Keane, Corinne
Briody, Julie
Hibbert, Sally
Poon, Myra
Padhye, Bhavna
Biggin, Andrew
Dalla-Pozza, Luciano
Gray, Randolph J.
Munns, Craig F.
- License Information
-
More Information
Article History
Received: 10 October 2022
Accepted: 30 January 2023
First Online: 21 February 2023
Declarations
: Denosumab was administered following approval from the Sydney Children's Hospitals Network Drug Committee.
: Joel A. Vanderniet, Dionysios Tsinas, Christie-Lee Wall, Christian M. Girgis, Kevin London, Corinne Keane, Julie Briody, Sally Hibbert, Myra Poon, Bhavna Padhye, Andrew Biggin, Luciano Dalla-Pozza, Randolph J. Gray and Craig F. Munns have no conflicts of interest to declare.
: This study was approved by the Human Research Ethics Committee at our institution (2019/ETH13024) and conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was not required for this retrospective review of clinical data, in which no identifying details were published.
